Birmingham, West Midlands -- (SBWIRE) -- 10/01/2013 -- Value Penny Stocks issues special report on Elite Pharmaceuticals Inc (OTCBB:ELTP) , Sigma Labs Inc(OTCMKTS:SGLB), Invivo Therapeutics Holdings Corp(OTCBB:NVIV), NYBD Holding Inc(OTCMKTS:NYBD)
Elite Pharmaceuticals Inc (OTCBB:ELTP) managed to keep its gain at 7.74% on below-normal volume of 2.96 million shares. The stock settled at $0.124 after floating in a range of $0.11 to $0.12. Its latest price was $0.124, reaching market capitalization of $49.99million. Its 52-week range has been $0.05 to $0.17. Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, principally engages in the research, development, and licensing of proprietary controlled-release drug delivery systems and products.
What was the Moving Force behind ELTP On Bullish Run? Read This Research Report on ELTP
Sigma Labs Inc(OTCMKTS:SGLB) traded up on a volume of 4.12 million, higher than its standard daily volume. Shares have gained 9.4% to $0.104. Over the last twelve months, the stock has added 593.33% and faced a best price of $0.14. Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and R&D solutions. It also focuses on commercializing technologies and products in various industry sectors, such as in process quality assurance for manufacturing.
For How Long SGLB will Fight for Profitability? Read This Trend Analysis report
Invivo Therapeutics Holdings Corp(OTCBB:NVIV) settled at $1.58 on below-normal volume of 386,981 shares during the last trading day. The stock has its 12-month high at $6.20 and 52-week low price was $0.94. It traded in a range of $0.01 to $0.01 during the last trading day. Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions.
Is NVIV a Solid Investment at These Levels? Read This Report For Details
NYBD Holding Inc(OTCMKTS:NYBD) saw its price gain on above-normal volume, as 19.21 million shares changed hands when compared with its average daily volume of 1.41 million shares. The stock was up 237.04% to $0.0091. It has fallen over the last 12 months, dropping -81.8% and marked new low $0.10. NYBD Holding, Inc., formerly League Now Holdings Corporation, through Infiniti Systems Group, Inc. (Infiniti), is a reseller for Microsoft and McAfee products for many of its clients. The Company markets its managed information technology (IT) services to the small to medium businesses. Its client base is across many industries, including healthcare, financial, manufacturing, construction, transportation, non-profits and government.
Why Should Investors Buy NYBD After The Recent Gain? Just Go Here and Find Out
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)